Certified by Founder Lodge
IMU Biosciences
United Kingdom - London
START UP
1 Disclosed Funding Rounds $14,639,787
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation h
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 25 ,2024 | Series A | $14,639,787 |
Molten Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
